BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9525832)

  • 1. The effect of dexamethasone on the uptake of cisplatin in 9L glioma and the area of brain around tumor.
    Straathof CS; van den Bent MJ; Ma J; Schmitz PI; Kros JM; Stoter G; Vecht CJ; Schellens JH
    J Neurooncol; 1998 Mar; 37(1):1-8. PubMed ID: 9525832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The accumulation of topotecan in 9L glioma and in brain parenchyma with and without dexamethasone administration.
    Straathof CS; van den Bent MJ; Loos WJ; Vecht CJ; Schellens JH
    J Neurooncol; 1999 Apr; 42(2):117-22. PubMed ID: 10421068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local distribution into brain tumor and pharmacokinetics of 4-pyridoxate diammine hydroxy platinum, a novel cisplatin derivative, after intracarotid administration in rats with 9L malignant glioma: simultaneous brain microdialysis study.
    Tokunaga Y; Nakashima M; Sasaki H; Tomiyama N; Nakashima MN; Ichikawa M; Kaminogo M; Shibata S
    Biol Pharm Bull; 2000 Dec; 23(12):1491-6. PubMed ID: 11145184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of dexamethasone on the uptake of p-boronophenylalanine in the rat brain and intracranial 9L gliosarcoma.
    Morris GM; Micca PL; Coderre JA
    Appl Radiat Isot; 2004 Nov; 61(5):917-21. PubMed ID: 15308168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of amifostine on cisplatin induced DNA adduct formation and toxicity in malignant glioma and normal tissues in rat.
    Bergström P; Johnsson A; Bergenheim T; Henriksson R
    J Neurooncol; 1999 Mar; 42(1):13-21. PubMed ID: 10360475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vivo microdialysis study of the distribution of cisplatin into brain tumour tissue after intracarotid infusion in rats with 9L malignant glioma.
    Nakashima M; Shibata S; Tokunaga Y; Fujita H; Anda T; Arizono K; Tomiyama N; Sasaki H; Ichikawa M
    J Pharm Pharmacol; 1997 Aug; 49(8):777-80. PubMed ID: 9379355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma.
    Zamboni WC; Gervais AC; Egorin MJ; Schellens JH; Zuhowski EG; Pluim D; Joseph E; Hamburger DR; Working PK; Colbern G; Tonda ME; Potter DM; Eiseman JL
    Cancer Chemother Pharmacol; 2004 Apr; 53(4):329-36. PubMed ID: 14673619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of nitric oxide manipulation on the disposition of platinum in an experimental glioma model.
    Malcolm GP; Jodrell DI; MacLellan A; Swaroop GR; Kelly PA; Whittle IR
    Neuroreport; 1998 Jan; 9(2):181-5. PubMed ID: 9507952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood flow and blood-to-tissue transport in 9L gliosarcomas: the role of the brain tumor model in drug delivery research.
    Fross RD; Warnke PC; Groothuis DR
    J Neurooncol; 1991 Dec; 11(3):185-97. PubMed ID: 1823340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone induces partial resistance to cisplatinum in C6 glioma cells.
    Wolff JE; Denecke J; Jürgens H
    Anticancer Res; 1996; 16(2):805-9. PubMed ID: 8687132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproducibility of O-(2-(18)F-fluoroethyl)-L-tyrosine uptake kinetics in brain tumors and influence of corticoid therapy: an experimental study in rat gliomas.
    Stegmayr C; Schöneck M; Oliveira D; Willuweit A; Filss C; Galldiks N; Shah NJ; Coenen HH; Langen KJ
    Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1115-23. PubMed ID: 26646781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platinum concentrations and DNA adduct levels in tumors and organs of cisplatin-treated LOU/M rats inoculated with cisplatin-sensitive or -resistant immunoglobulin M immunocytoma.
    Fichtinger-Schepman AM; Vendrik CP; van Dijk-Knijnenburg WC; de Jong WH; van der Minnen AC; Claessen AM; van der Velde-Visser SD; de Groot G; Wubs KL; Steerenberg PA
    Cancer Res; 1989 Jun; 49(11):2862-7. PubMed ID: 2720647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cereport (RMP-7) increases carboplatin levels in brain tumors after pretreatment with dexamethasone.
    Dean RL; Emerich DF; Hasler BP; Bartus RT
    Neuro Oncol; 1999 Oct; 1(4):268-74. PubMed ID: 11550318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetics of plasma and cerebrospinal fluid cisplatin in patients with malignant glioma and metastatic brain tumor after selective intraarterial or intravenous and intracarotid administration of etoposide and cisplatin].
    Nakagawa H; Miyawaki Y; Tokiyoshi K; Tsuruzono K; Yamada M; Kanayama T; Hayakawa T
    No Shinkei Geka; 1994 Jan; 22(1):35-42. PubMed ID: 8295700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect on the tumor vessel permeability by hyperosmotic blood brain barrier disruption].
    Miyagami M; Tazoe M; Kagawa Y; Tsubokawa T
    No To Shinkei; 1988 Sep; 40(9):875-82. PubMed ID: 3142506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomes as carriers of cisplatin into the central nervous system--experiments with 9L gliomas in rats.
    Shibata S; Ochi A; Mori K
    Neurol Med Chir (Tokyo); 1990 Apr; 30(4):242-5. PubMed ID: 1696693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue distribution and antitumor activity of topotecan delivered by intracerebral clysis in a rat glioma model.
    Kaiser MG; Parsa AT; Fine RL; Hall JS; Chakrabarti I; Bruce JN
    Neurosurgery; 2000 Dec; 47(6):1391-8; discussion 1398-9. PubMed ID: 11126910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of cellular factors and pharmacokinetics on the formation of platinum-DNA adducts in leukocytes of children receiving cisplatin therapy.
    Veal GJ; Dias C; Price L; Parry A; Errington J; Hale J; Pearson AD; Boddy AV; Newell DR; Tilby MJ
    Clin Cancer Res; 2001 Aug; 7(8):2205-12. PubMed ID: 11489793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inter- and intratumoral disposition of platinum in solid tumors after administration of cisplatin.
    Zamboni WC; Gervais AC; Egorin MJ; Schellens JH; Hamburger DR; Delauter BJ; Grim A; Zuhowski EG; Joseph E; Pluim D; Potter DM; Eiseman JL
    Clin Cancer Res; 2002 Sep; 8(9):2992-9. PubMed ID: 12231546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone enhances calcium-activated potassium channel expression in blood-brain tumor barrier in a rat brain tumor model.
    Gu YT; Xue YX; Wang P; Zhang H; Qin LJ; Liu LB
    Brain Res; 2009 Mar; 1259():1-6. PubMed ID: 19401176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.